'Claim of stated study is not known': Govt asks Patanjali to stop advertising its coronavirus drug until 'issue' is examined
New Delhi | Jagran News Desk: Hours after Patanjali Ayurved Ltd launched its Ayurvedic medicine Coronil to treat COVID-19 patients, the central government that the facts of the "claim and details of the stated scientific study are not known" and asked the company to stop advertising and publicising such claims till the issue is duly examined.
In a statement, the Ministry of AYUSH said that the complete details of the supposed medicines have been sought, adding that Patanjali has been asked to provide at the earliest details of name and composition of medicine being claimed for COVID treatment.
"The concerned Ayurvedic drug manufacturing company has been informed that such advertisements of drugs including Ayurvedic medicines are regulated under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder and the directives issued by the Central Government in the wake of COVID outbreak. Ministry had also issued a Gazette Notification No. L.11011/8/2020/AS dated 21st April, 2020 stating the requirements and the manner the research studies on COVID-19 with Ayush interventions/medicines should be undertaken," it said.
"Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined," it added.
Patanjali on Tuesday launched its Ayurvedic medicine Coronil and claimed that the medicine can cure the highly contagious disease within seven days.
The company said that the medicine had shown 100 per cent favourable results during clinical trials on COVID-19 infected patients except those on a life support system.
"The medicines have been developed by Patanjali Research Center, Haridwar and privately-owned National Institute of Medical Science, Jaipur following all protocols with clinically controlled trial-based evidence," Ramdev told news agency PTI.
"This was done after getting approval from Clinical Trial Registry of India (CTRI) and all other required formalities. We have followed all the parameters set up by modern science for such clinical trials," he added.
Patanjali's anti-COVID tablet, Divya Coronil Tablet consists of Giloy, Tulsi and Ashwagandha and is prescribed to be taken thrice a day with hot water 30 minutes after breakfast, lunch and dinner. Medical experts, however, were not convinced by the claims made by Yoga guru Ramdev's Patanjali.
Posted By: Aalok Sensharma